Alliancebernstein L.P. Cara Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

  • $275 Billion
  • Q1 2024

A detailed history of Alliancebernstein L.P. transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 87,320 shares of CARA stock, worth $28,815. This represents 0.0% of its overall portfolio holdings.

Number of Shares
87,320
Previous 87,320 -0.0%
Holding current value
$28,815
Previous $64,000 23.44%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$0.6 - $1.65 $3,540 - $9,735
-5,900 Reduced 6.33%
87,320 $64,000
Q2 2023

Aug 15, 2023
BUY
$2.83 - $4.94 $129,670 - $226,350
45,820 Added 96.67%
93,220 $263,000
Q1 2023

May 15, 2023
SELL
$4.89 - $12.27 $32,572 - $81,730
-6,661 Reduced 12.32%
47,400 $232,000
Q4 2022

Feb 14, 2023
BUY
$8.88 - $12.77 $32,332 - $46,495
3,641 Added 7.22%
54,061 $580,000
Q3 2022

Nov 15, 2022
BUY
$8.24 - $12.56 $40,903 - $62,347
4,964 Added 10.92%
50,420 $472,000
Q2 2022

Aug 15, 2022
BUY
$7.45 - $13.84 $938 - $1,743
126 Added 0.28%
45,456 $415,000
Q1 2022

May 13, 2022
BUY
$9.94 - $12.65 $1,073 - $1,366
108 Added 0.24%
45,330 $551,000
Q4 2021

Feb 14, 2022
SELL
$11.99 - $18.14 $116,279 - $175,921
-9,698 Reduced 17.66%
45,222 $551,000
Q3 2021

Nov 10, 2021
SELL
$11.55 - $16.06 $25,063 - $34,850
-2,170 Reduced 3.8%
54,920 $849,000
Q2 2021

Jul 30, 2021
BUY
$12.38 - $29.19 $100,154 - $236,147
8,090 Added 16.51%
57,090 $815,000
Q4 2020

Feb 08, 2021
SELL
$12.72 - $16.16 $161,544 - $205,232
-12,700 Reduced 20.58%
49,000 $741,000
Q3 2020

Nov 12, 2020
SELL
$12.34 - $17.92 $22,212 - $32,256
-1,800 Reduced 2.83%
61,700 $785,000
Q2 2020

Aug 13, 2020
BUY
$12.39 - $17.33 $221,781 - $310,206
17,900 Added 39.25%
63,500 $1.09 Million
Q4 2019

Feb 18, 2020
BUY
$16.11 - $25.98 $33,831 - $54,558
2,100 Added 4.83%
45,600 $735,000
Q2 2019

Aug 14, 2019
SELL
$17.68 - $21.57 $1.42 Million - $1.73 Million
-80,390 Reduced 64.89%
43,500 $935,000
Q1 2019

May 14, 2019
SELL
$14.41 - $19.64 $83,578 - $113,912
-5,800 Reduced 4.47%
123,890 $2.43 Million
Q4 2018

Feb 13, 2019
BUY
$12.45 - $23.47 $1.07 Million - $2.02 Million
85,990 Added 196.77%
129,690 $1.69 Million
Q3 2018

Nov 08, 2018
SELL
$17.57 - $23.95 $65,009 - $88,615
-3,700 Reduced 7.81%
43,700 $1.05 Million
Q2 2018

Aug 13, 2018
SELL
$11.6 - $19.27 $73,080 - $121,401
-6,300 Reduced 11.73%
47,400 $908,000
Q1 2018

May 14, 2018
BUY
$11.77 - $16.08 $177,727 - $242,807
15,100 Added 39.12%
53,700 $665,000
Q3 2017

Nov 13, 2017
BUY
$12.6 - $16.34 $486,360 - $630,724
38,600
38,600 $528,000

Others Institutions Holding CARA

# of Institutions
102
Shares Held
21.5M
Call Options Held
50K
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $17.7M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email